Cargando…

On the lag phase in amyloid fibril formation

The formation of nanoscale amyloid fibrils from normally soluble peptides and proteins is a common form of self-assembly phenomenon that has fundamental connections with biological functions and human diseases. The kinetics of this process has been widely studied and exhibits on a macroscopic level...

Descripción completa

Detalles Bibliográficos
Autores principales: Arosio, Paolo, Knowles, Tuomas P. J., Linse, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498454/
https://www.ncbi.nlm.nih.gov/pubmed/25719972
http://dx.doi.org/10.1039/c4cp05563b
_version_ 1782380626405490688
author Arosio, Paolo
Knowles, Tuomas P. J.
Linse, Sara
author_facet Arosio, Paolo
Knowles, Tuomas P. J.
Linse, Sara
author_sort Arosio, Paolo
collection PubMed
description The formation of nanoscale amyloid fibrils from normally soluble peptides and proteins is a common form of self-assembly phenomenon that has fundamental connections with biological functions and human diseases. The kinetics of this process has been widely studied and exhibits on a macroscopic level three characteristic stages: a lag phase, a growth phase and a final plateau regime. The question of which molecular events take place during each one of these phases has been a central element in the quest for a mechanism of amyloid formation. In this review, we discuss the nature and molecular origin of the lag-phase in amyloid formation by making use of tools and concepts from physical chemistry, in particular from chemical reaction kinetics. We discuss how, in macroscopic samples, it has become apparent that the lag-phase is not a waiting time for nuclei to form. Rather, multiple parallel processes exist and typically millions of primary nuclei form during the lag phase from monomers in solution. Thus, the lag-time represents a time that is required for the nuclei that are formed early on in the reaction to grow and proliferate in order to reach an aggregate concentration that is readily detected in bulk assays. In many cases, this proliferation takes place through secondary nucleation, where fibrils may present a catalytic surface for the formation of new aggregates. Fibrils may also break (fragmentation) and thereby provide new ends for elongation. Thus, at least two – primary nucleation and elongation – and in many systems at least four – primary nucleation, elongation, secondary nucleation and fragmentation – microscopic processes occur during the lag phase. Moreover, these same processes occur during all three phases of the macroscopic aggregation process, albeit at different rates as governed by rate constants and by the concentration of reacting species at each point in time.
format Online
Article
Text
id pubmed-4498454
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-44984542015-07-15 On the lag phase in amyloid fibril formation Arosio, Paolo Knowles, Tuomas P. J. Linse, Sara Phys Chem Chem Phys Chemistry The formation of nanoscale amyloid fibrils from normally soluble peptides and proteins is a common form of self-assembly phenomenon that has fundamental connections with biological functions and human diseases. The kinetics of this process has been widely studied and exhibits on a macroscopic level three characteristic stages: a lag phase, a growth phase and a final plateau regime. The question of which molecular events take place during each one of these phases has been a central element in the quest for a mechanism of amyloid formation. In this review, we discuss the nature and molecular origin of the lag-phase in amyloid formation by making use of tools and concepts from physical chemistry, in particular from chemical reaction kinetics. We discuss how, in macroscopic samples, it has become apparent that the lag-phase is not a waiting time for nuclei to form. Rather, multiple parallel processes exist and typically millions of primary nuclei form during the lag phase from monomers in solution. Thus, the lag-time represents a time that is required for the nuclei that are formed early on in the reaction to grow and proliferate in order to reach an aggregate concentration that is readily detected in bulk assays. In many cases, this proliferation takes place through secondary nucleation, where fibrils may present a catalytic surface for the formation of new aggregates. Fibrils may also break (fragmentation) and thereby provide new ends for elongation. Thus, at least two – primary nucleation and elongation – and in many systems at least four – primary nucleation, elongation, secondary nucleation and fragmentation – microscopic processes occur during the lag phase. Moreover, these same processes occur during all three phases of the macroscopic aggregation process, albeit at different rates as governed by rate constants and by the concentration of reacting species at each point in time. Royal Society of Chemistry 2015-03-28 2015-02-26 /pmc/articles/PMC4498454/ /pubmed/25719972 http://dx.doi.org/10.1039/c4cp05563b Text en This journal is © The Royal Society of Chemistry 2015 http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Chemistry
Arosio, Paolo
Knowles, Tuomas P. J.
Linse, Sara
On the lag phase in amyloid fibril formation
title On the lag phase in amyloid fibril formation
title_full On the lag phase in amyloid fibril formation
title_fullStr On the lag phase in amyloid fibril formation
title_full_unstemmed On the lag phase in amyloid fibril formation
title_short On the lag phase in amyloid fibril formation
title_sort on the lag phase in amyloid fibril formation
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498454/
https://www.ncbi.nlm.nih.gov/pubmed/25719972
http://dx.doi.org/10.1039/c4cp05563b
work_keys_str_mv AT arosiopaolo onthelagphaseinamyloidfibrilformation
AT knowlestuomaspj onthelagphaseinamyloidfibrilformation
AT linsesara onthelagphaseinamyloidfibrilformation